The new funding will help the cluster build on initial milestones and to prepare for clinical applications, particularly in cancer.

Researchers have identified a promising new weapon against triple-negative breast cancer, one of the most aggressive forms of the disease. An experimental antibody targets a protein that fuels tumor ...

The market for antibody specificity testing is undergoing a remarkable expansion due to the progressive biotechnological innovations and the ever-increasing demand for accurate diagnostic tools. As ...

This important study sought to investigate the role that early childhood malaria exposure plays in the development of antibody responses to unrelated pathogens and vaccine-derived antigens in Kenyan ...

An international research team led by the University of Cologne has discovered an antibody that could advance the fight against HIV. The newly identified antibody 04_A06 proved to be particularly ...

In Sarah Yuska’s sixth-grade science class at Monocacy Middle School in Frederick, Maryland, students are just finishing up learning about body systems—respiratory, circulatory, skeletal, and so on.

Ever since Biogen and Eisai’s Aduhelm (aducanemab) was approved in 2021 as the first antibody to treat Alzheimer’s disease by clearing amyloid plaques from the brain, the modality has been dogged by a ...

PEPperPRINT has launched its next-generation peptide microarray platform: cLIFT, short for combinatorial Laser-Induced Forward Transfer. Offering a powerful upgrade to the company’s proprietary laser ...

Helen Branswell covers issues broadly related to infectious diseases, including outbreaks, preparedness, research, and vaccine development. Follow her on Mastodon and Bluesky. You can reach Helen on ...